Literature DB >> 30903797

The Future of the GLP-1 Receptor Agonists.

Irl B Hirsch1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30903797     DOI： 10.1001/jama.2019.2941

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  3 in total

1.  Effect of the Gintonin-Enriched Fraction on Glucagon-Like-Protein-1 Release.

Authors:  Rami Lee; Sun-Hye Choi; Han-Sung Cho; Hongik Hwang; Hyewhon Rhim; Hyoung-Chun Kim; Sung-Hee Hwang; Seung-Yeol Nah
Journal:  Molecules       Date:  2021-10-18       Impact factor: 4.411

Review 2.  GLP-1 Receptor Agonists: Beyond Their Pancreatic Effects.

Authors:  Xin Zhao; Minghe Wang; Zhitong Wen; Zhihong Lu; Lijuan Cui; Chao Fu; Huan Xue; Yunfeng Liu; Yi Zhang
Journal:  Front Endocrinol (Lausanne)       Date:  2021-08-23       Impact factor: 5.555

3.  Effects of glucagon-like peptide 1 receptor agonists and sodium glucose cotransporter 2 inhibitors on major adverse cardiovascular events in type 2 diabetes by race, ethnicity, and region: A meta-analysis.

Authors:  Mei Qiu; Liangliang Ding; Xubin Wei; Wei Wei; Hairong Zhou
Journal:  Medicine (Baltimore)       Date:  2020-12-04       Impact factor: 1.817
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.